AKER HAZEL M

Insider profile

Performance

Overall performance
2.3

Performance over holding periods
2.3
30 days 90 days 120 days
Average return 16% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
AKER HAZEL M's trades of Oncternal Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2020-07-23 2020-07-21 B Purchase
58,666 -46.9%
291.47
US$3,927,731
58,666 -46.9% 291.47 US$3,927,731